Image

Safety and Efficacy of VDPHL01 in Females With Androgenetic Alopecia (AGA)

Testing VDPHL01 for hair loss treatment in women.

Recruiting
18-65 years
Female
Phase 3
  • Simplified description (AI rewritten)
  • Technical description (Original)

The study tests the safety and effectiveness of an oral drug called VDPHL01 for women with Androgenetic Alopecia (AGA), a genetic condition where hair falls out due to hormone reactions. The study is "multi-center" (happening in different places) and "double-blind" (neither the participants nor the researchers know who gets the real drug or a placebo). It lasts about 13 months and involves 11 visits to the study site. Participants should be women aged 18-65 with mild to moderate AGA, generally healthy, and willing to keep their hairstyle and color the same.

  • Length of Study: About 13 months with 11 visits.
  • Participant Requirements: Must keep hair style consistent, be able to swallow pills, and agree to scalp tattoo and photos.
  • Exclusions: Certain health conditions, recent COVID-19, and recent use of specific hair or health treatments.
Print
Study details
    Androgenetic Alopecia (AGA)
    Androgenetic Alopecia
    AGA
    Female Androgenetic Alopecia
    Hair Loss

NCT07146022

Veradermics, Inc.

7 March 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Race
Ethnicity
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.